Anne-Genevieve Marcelin is Professor of Virology at Sorbonne Université in Paris, France and clinical virologist at the Pitié-Salpêtrière Hospital. She’s head of a research team (Inserm UMR 1136) dedicated to Therapeutic strategies for HIV infection and associated viral diseases.
Pr Anne-Genevieve Marcelin research interests include HIV mechanisms of resistance to antiretrovirals, new therapy strategies for HIV treatment and new antiretroviral agents. She has been also involved in SARS-CoV-2 research studies: evaluation of antibodies response to Covid-19 infection and vaccination in caregivers and immunocompromised patients. She serves as a member of Agence Nationale de Recherche sur le SIDA et les hepatites virales – Maladies Infectieuses Emergentes (ANRS-MIE), in the French AC43 resistance group (www.hivfrenchresistance.org).
